aiqbenchInformații despre AI & calcul cuantic

...

Română · beta. Traducerea a fost făcută automat și este încă în curs de revizuire. Citește pagina în engleză

perspectiva aiqbenchProduse AI

This article details a clinical milestone where Science Corporation implanted its PRIMA chip to restore vision in a Stargardt disease patient, framing retinal prosthetics as a specific application of brain-computer interface technology. The core subject is the advancement of neural engineering and medical devices designed to interface directly with the nervous system to treat blindness, which falls squarely within the domain of applied machine learning and bio-integrated hardware.

Sursă care acoperăTechCrunch

Ce este aceastaLectura unui model asupra articolului și a acoperirii conexe, scrisă pentru aiqbench. Nu sunt cuvintele publicației.

Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

TechCrunch13 octombrie 20264 min de cititArticolul și perspectiva sunt în engleză.

Max Hodak, the former president and co-founder of Neuralink, detailed onstage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).

Science Corporation CEO Max Hodak announced that the company has implanted its vision-restoring chip, PRIMA, into its first patient with Stargardt disease, an inherited eye disease that gradually destroys central vision. Hodak, the former president and co-founder of Neuralink, the brain implant company, explained on stage at TechCrunch Disrupt how the company’s work with PRIMA fits into its broader pursuit of a novel brain-computer interface (BCI). “The retina is part of the central nervous system,” Hodak said on stage. “We consider cochlear implants, retinal…

Extras afișat conform termenilor RSS ai publicației · 84 cuvinte · textul integral și figurile sunt pe site-ul publicației

Citește pe TechCrunch ↗Întreabă despre acest articol